In today’s increasingly complex pharmaceutical distribution system and highly active cross-border trade environment, counterfeit medicines have evolved from a national regulatory issue into a global

As Semaglutide, Tirzepatide, and next-generation multi-target peptides like Retatrutide advance in development and commercialization, China’s peptide API industry is entering a new capacity expansion cycle.

Over the past five years, the global weight-loss drug market has evolved from GLP-1 single-target to dual-target therapies, driving peptides from early research into large-scale

In the global pharmaceutical supply chain, drug transportation is no longer a simple logistics process. It has evolved into a highly specialized system focused on

Spinal muscular atrophy (SMA) has seen continuous advances in spinal muscular atrophy research, clinical treatment, and long-term disease management in recent years. With the expanding

Key Takeaways Understand the overall system: Modern cancer treatment in China has developed into a multidisciplinary, tiered system covering surgery, radiotherapy, systemic therapy, immunotherapy, and